Decision path
Use the guide as a safety framework.
Learn the framework first, then check risk, vendor documentation, and personal fit before choosing a compound path.
01
Learn the framework
02
Check risk
03
Take the quiz
04
Compare vendors
Guide next step
Use the guide before choosing a compound.
Take the quiz after this guide so the next page reflects your goal, risk tolerance, and monitoring comfort.
Why this matters
Most new users do not need advanced protocols first. They need orientation.
Good FAQ content lowers confusion without oversimplifying the subject.
This page can absorb repeat beginner questions before they leak into every other page.
Key takeaways
Start with goal, evidence, and risk instead of the loudest compound name you have seen online.
Use guide pages to learn the framework before comparing vendor pages.
If the product documentation is weak, slow down. That is part of the evaluation.
The personalized plan can help, but the guides should still make sense on their own.
Guide protocol path
Use this framework before turning research into a protocol.
- 1
Baseline
Clarify goal, labs, contraindications, and sport/testing status.
- 2
Choose
Pick one primary compound path before stacking extras.
- 3
Source
Check vendor documentation, COA fit, and route constraints.
- 4
Monitor
Track outcomes, adverse effects, and stop conditions.
- 5
Reassess
Review whether the protocol still fits after the first cycle.
Questions new users usually start with
The best way to use this site
Start with a guide page if the category is new to you.
Use peptide pages to compare evidence, risk, and route.
Use goal hubs to narrow the field by outcome.
Use vendor pages only after you understand the kind of compound and listing you are looking at.
Frequently asked questions
If you are new to the category, start with the guides. If you already know the basic framework and want a faster path through the catalog, the quiz can help narrow the field.
Because evidence, safety, and regulatory context should be obvious, not buried where people miss them.
Sources and review notes
- Certain Bulk Drug Substances for Use in Compounding that May Present Significant Safety Risks - U.S. Food and Drug Administration - accessed 2026-05-15
Used for FDA compounding-risk context and peptide safety flags.
- The Prohibited List - World Anti-Doping Agency - accessed 2026-05-15
Used for athlete-facing WADA risk and peptide-class restrictions.
- Peptide therapeutics: current status and future directions - PubMed / Nature Reviews Drug Discovery - accessed 2026-05-15
Used for broad peptide-therapeutics background and evidence framing.
Use these guides to build confidence first — then compare compounds, review vendor documentation, and take the quiz when you're ready for a plan.